5'-Nucleotides as potential formulations for administering nucleoside analogs in man.
D000227:Adenine Nucleotides / Q000378:metabolism; D000328:Adult; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism; D001089:Arabinose / Q000096:biosynthesis / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000378:metabolism; D006224:Cricetinae; D004285:Dogs; D006801:Humans; D007042:Hypoxanthines / Q000378:metabolism; D007668:Kidney / Q000201:enzymology / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000378:metabolism; D008175:Lung Neoplasms / Q000378:metabolism; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism; D008297:Male; D015122:Mercaptopurine / Q000378:metabolism; D051379:Mice; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D009705:Nucleosides / Q000096:biosynthesis* / Q000097:blood; D009708:Nucleotidases / Q000378:metabolism; D009711:Nucleotides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D010758:Phosphorus; D011817:Rabbits; D013460:Sulfur Isotopes; D013997:Time Factors; D014316:Tritium
D000227:Adenine Nucleotides; D000903:Antibiotics, Antineoplastic; D007042:Hypoxanthines; D009705:Nucleosides; D009711:Nucleotides; D013460:Sulfur Isotopes; D014316:Tritium; D010758:Phosphorus; D001089:Arabinose; D015122:Mercaptopurine; D009708:Nucleotidases